Fourth, Cameron et al. [87] observed that besides the disease status, in pediatric samples with Inflammatory Bowel Disease, the outcome of an antitumor necrosis factor (TNF) therapy depended from participants’ pubertal stage. The gene discussed is TNF; the disease is inflammatory bowel disease.